0I8C Stock Overview
Engages in the manufacture and sale of ingredients for cosmetic industry in Norway.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Aqua Bio Technology ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 4.65 |
| 52 Week High | NOK 5.68 |
| 52 Week Low | NOK 4.65 |
| Beta | 0.76 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -72.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0I8C | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0% | -2.5% | -1.4% |
| 1Y | n/a | -32.7% | 6.6% |
Return vs Industry: Insufficient data to determine how 0I8C performed against the UK Chemicals industry.
Return vs Market: Insufficient data to determine how 0I8C performed against the UK Market.
Price Volatility
| 0I8C volatility | |
|---|---|
| 0I8C Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 7.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.1% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0I8C has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0I8C's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 4 | Havard Lindstrom | aquabiotechnology.com |
Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics.
Aqua Bio Technology ASA Fundamentals Summary
| 0I8C fundamental statistics | |
|---|---|
| Market cap | NOK 261.80m |
| Earnings (TTM) | -NOK 1.50m |
| Revenue (TTM) | NOK 13.82m |
18.9x
P/S Ratio-174.2x
P/E RatioIs 0I8C overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0I8C income statement (TTM) | |
|---|---|
| Revenue | NOK 13.82m |
| Cost of Revenue | NOK 4.50m |
| Gross Profit | NOK 9.32m |
| Other Expenses | NOK 10.82m |
| Earnings | -NOK 1.50m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Jun 14, 2024
| Earnings per share (EPS) | -0.026 |
| Gross Margin | 67.43% |
| Net Profit Margin | -10.88% |
| Debt/Equity Ratio | 264.7% |
How did 0I8C perform over the long term?
See historical performance and comparison